Skip to main content
. 2020 Oct 28;21(21):8038. doi: 10.3390/ijms21218038
α-SMA α-smooth muscle actin
ACE angiotensin converting enzyme
ACEIs angiotensin converting enzyme inhibitors
Ac-SDKP N-acetyl-seryl-aspartyl-lysyl-proline
ADAM17 tumor necrosis factor-α-converting enzyme (TACE)
ALI acute lung injury
Ang angiotensin
APA aminopeptidase A
APM aminopeptidase M
ARBs angiotensin II type 1 receptor blockers
ARDS acute respiratory distress syndrome
AT1R angiotensin II type 1 receptor
AT2R angiotensin II type 2 receptor
BAL bronchoalveolar lavage
BLM bleomycin
CATA cathepsin A
CINC-3 cytokine-induced neutrophil chemoattractant 3
COPD chronic obstructive pulmonary disease
CxA carboxypeptidase A
CXCL5 C-X-C motif chemokine 5
DABK des-Arg9-bradykinin
DOCA deoxycorticosterone acetate
FiO2 fraction of inspired oxygen
GM-CSF granulocyte-macrophage colony-stimulating factor
HD high dose
ICU intensive care unit
IL interleukin
i.p. intraperitoneally
i.v. intravenously
KC C-X-C motif chemokine 1
LD low dose
LPS lipopolysaccharide
mACE2 membrane-bound angiotensin converting enzyme 2
MasR Mas receptor
MCP-1 monocyte chemoattractant protein-1
MIP2 macrophage inflammatory protein-2
MLDAD mononuclear leukocyte-derived aspartate decarboxylase
MrgD Mas-Related G-Protein Coupled Receptor D
NEP neprilysin
PaCO2 partial pressure of carbon dioxide
PaO2 partial pressure of oxygen
POP propyl oligopeptidase
PKC-δ protein kinase C-δ
RAS renin–angiotensin system
rhACE2 recombinant human angiotensin converting enzyme 2
sACE2 soluble angiotensin converting enzyme 2
s.c. subcutaneously
T2D type 2 diabetes mellitus
TACE tumor necrosis factor-α-converting enzyme (ADAM17)
TGF-β1 transforming growth factor β1
TLR toll like receptor
TMPRSS2 transmembrane protease serine 2
TNF-α tumor necrosis factor-α
WBC white blood cells